Biguanide
Metformin hydrochloride
Brand names: Glucophage, Metformin SR
Adult dose
Dose: 500mg OD with food; titrate weekly to 500–1000mg BD–TDS (max 3g/day in divided doses or 2g/day MR)
Route: PO
Frequency: OD-TDS
Dose adjustments
Renal
eGFR 30–45: max 1g/day, monitor; eGFR <30 avoid (MHRA 2016)
Clinical pearls
- First-line for type 2 DM (NICE NG28); useful in PCOS
- MR formulations improve GI tolerance
Contraindications
- eGFR <30
- DKA
- Severe hepatic impairment
- Acute heart failure / hypoxia / sepsis
- Concurrent IV iodinated contrast (hold around procedure if eGFR <60)
Side effects
- GI upset (very common — start low, titrate)
- Lactic acidosis (rare, at-risk patients)
- Vitamin B12 deficiency (long-term, MHRA warning)
- Metallic taste
Interactions
- Iodinated contrast (hold)
- Alcohol
- Cimetidine (raised levels)
- ACE inhibitors / NSAIDs (renal)
Monitoring
- HbA1c
- Renal function
- Vitamin B12 (yearly long-term)
Reference: BNF; NICE NG28; MHRA Drug Safety Update; https://bnf.nice.org.uk/drugs/metformin-hydrochloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016